Drug intelligence / Profile preview

Kangguzengsheng

Development stage
Phase 1
Lead developer
Fuzhou Minhai Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Kangguzengsheng (also known as Kangguzengsheng Pian or Kanggu Zengsheng Wan) is a traditional Chinese medicine formula used primarily for the treatment of musculoskeletal conditions such as hyperostosis, hypertrophic spondylitis, cervical spondylosis, heel spurs, and proliferative arthritis[1][2][8]. The formulation consists of multiple herbal ingredients including Radix Rehmanniae Preparata, Herba Cistanches (steamed), Rhizoma Cibotii (processed with salt), Fructus Ligustri Lucidi (processed with salt), Herba Epimedii, Caulis Spatholobi, Semen Raphani (stir-baked), Rhizoma Drynariae, and Radix Achyranthis Bidentatae[8]. Its mechanism of action involves modulation of several biological pathways related to inflammation and bone metabolism. Network pharmacology and molecular docking studies suggest that active components in the formula interact with targets such as Estrogen receptor 1 (ESR1), Interferon gamma (IFNG), Interleukin-1 beta (IL1B), Nuclear factor kappa B subunit 1 (NFKB1), and Tumor necrosis factor (TNF)[3][4]. These interactions are believed to alleviate symptoms by influencing inflammatory signaling pathways like IL-17 and TNF pathways. The product is approved for use in China for skin and musculoskeletal diseases—specifically hyperostosis—and is manufactured by companies such as Fuzhou Minhai Pharmaceutical[2].

Brand names
Kangguzengsheng PianKanggu Zengsheng Wan
Other names
Kangguzengsheng TabletsKGZST
02

Targets

ESR1 (ERα)IFNG (Interferon gamma)IL1B (Interleukin-1 beta)NFKB1 (NF-κB1)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Kangguzengsheng.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kangguzengsheng.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call